Replies to post #14318 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

That would be acceptable to me. lol

[glbeaty]

There is no way they have presentable patient data.

AIM2CERV is designed to test AXAL's ability to prevent recurrence. Recurrence of cancer takes months or years. The first patient was dosed a month ago.

To address another comment, AIM2CERV likely has many patients enrolled, as enrollment occurs before they receive chemo/radiation treatment as per my email with IR. This is why it took so long to dose the first patient.